Contra-Indications; Side - Effects - Enraf Nonius CURAPULS 670 Manuel De Instrucciones

Ocultar thumbs Ver también para CURAPULS 670:
Tabla de contenido

Publicidad

Idiomas disponibles
  • ES

Idiomas disponibles

  • ESPAÑOL, página 172

8 CONTRA-INDICATIONS

The CURAPULS 670 MUST NOT be used during or for:
• Patients with Pacemakers
• Pregnancy
• Current tissue bleeding.
• Malignancy
• Active tuberculosis
• Treatment of the abdomen and pelvis during menstruation.
• Severe circulatory compromise or deficit including ischaemic tissue, thrombosis and
associated conditions
• Deep X Ray therapy or other ionizing radiations (in the last 6 months) in the region to be
treated.
• Patients who are unable to comprehend the therapist's instructions or who are unable
to cooperate.
• Implanted metals
• Active epiphyseal regions in children
• Specialized tissues (e.g. eye and testes)
• Fever
• Bacterial infections
• Heart disorders
• Thermic sensibility disorders
Do not administer shortwave when a patient had an implanted lead in the past unless
you are sure that the implant and all leads in their entirety have been removed. Note
that leads are often left implanted after the implant is removed.
It is considered safe to deliver a low dose (less than 5 Watts mean power) when there
is metal in the tissues. Metal plinths are generally considered acceptable when the
applied mean power is less than 5 Watts.
Do NOT use shortwave diathermy in patients with breast implants, as it has been
reported to cause tissue necrosis, skin erosion, and implant extrusion.
S
-
IDE
EFFECTS
No Side effects are reported due to the normal use of CURAPULS 670.
EN109-1670750-46 IFU
Page 12 of 34
ENGLISH

Publicidad

Tabla de contenido
loading

Tabla de contenido